Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
Completed · Phase 1/Phase 2
Conditions studied: Child Development Disorders, Pervasive
In brief
The purpose of this study is to determine if the known differences in genes influence drug metabolizing enzymes and receptors that are involved in risperidone drug action. The study will determine if differences in these genes will change the concentration of risperidone in the blood over time in children in relation to side effects and clinical response to risperidone.
Key facts
- Study ID
- NCT00166595
- Run by
- Children's Hospital Medical Center, Cincinnati
- People needed
- 100
- Starts
- 2003-02-01
- Expected to finish
- 2005-03-01
- Last updated by the study team
- 2014-01-28
Who can join
Age: 4 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male and female patients between the ages of 4 and 21 years.
- Patients meeting DSM-IV criteria for autistic disorder, Pervasive Developmental Disorder (PDD), or Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) and about to initiate clinical treatment or currently clinically treated with risperidone.
- Patients about to initiate clinical treatment or currently clinically treated with risperidone, or currently on risperidone as a participant in one of the multi-site Research Unit for Pediatric Psychopharmacology (RUPP) protocols.
You may not qualify if…
- Children taking psychotropic or other medication that will significantly interact with target CYP 450 isoenzyme activity, such to the discretion of the principal investigator (PI).
- Patients with known renal or hepatic dysfunction (e.g. serum creatinine, and transaminases or bilirubin exceeding age specific upper range limits) are not eligible.
- Failure of the parent/legal guardian to give informed consent.
Where it is running
- Children's Hospital of Michigan/Wayne State University — Detroit, Michigan, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
- The Ohio State University Medical Center — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.